Banco Bradesco S.A. (0HL8)
London Exchange · UK · prices in USD · close of 22 Oct 2026
Key indicators
| Last close | USD 3.990 |
|---|---|
| 52-week range | 3.220 – 4.890 |
| Return, 1 month / 3 months | +14.7% / +13.8% |
| Return, 1 year / 3 years | +27.9% / +73.4% |
| Trend | Uptrend |
| RSI (14) | 55 |
| Volatility (1 year) | 39.3% |
| Worst drawdown (1 year) | -21.9% |
| Average daily value traded | 0.08M USD |
| Dividend yield | 1.0% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Bradesco is a Brazilian financial services group based in Osasco, in the state of São Paulo. It offers retail and commercial banking to individuals and companies, including current accounts, savings, personal and business loans, credit cards and payroll lending. The group also provides insurance, private pension plans, leasing and asset management through its affiliated companies. Its customers range from individual savers and small businesses to large corporate clients across Brazil, and it serves them through a nationwide branch network and digital channels.
On this site Banco Bradesco S.A. appears as a stock on the London Exchange (UK), code 0HL8, with prices in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Bradesco S.A. (0HL8) trades on the London Exchange in UK. It last closed at USD 3.990 on 22 October 2026.
Its price-based Market X-Ray is 54 out of 100 (a fair price profile), ranking 1,817 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 27.9% and over the last three months it rose 13.8%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 64 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 10.5% | ||
| From 52-week high | -12.7% | ||
| Momentum | 65 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 13.8% | ||
| 6-month return | 0.8% | ||
| 12-month return, skipping the last month | 11.6% | ||
| Stability (higher is calmer) | 55 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 39.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -21.9% | ||
| Liquidity | 20 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.08M USD | ||
| Zero-volume days | 36.7% | ||
| Income | 50 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.0% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | +14.7% |
| 3 months | +13.8% |
| 6 months | +0.8% |
| 1 year | +27.9% |
| 3 years | +73.4% |
| 5 years | −89.8% |
Signals
| 50-day / 200-day average | 3.661 / 3.610 |
|---|---|
| Golden / death cross (60 days) | Golden, 7 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.185 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 15 Oct 2026 | BRL 0.0455 |
| 5 Oct 2026 | BRL 0.0023 |
| 21 Sep 2026 | BRL 0.0002 |
| 3 Sep 2026 | BRL 0.0023 |
| 5 Aug 2026 | BRL 0.0023 |
| 7 Jul 2026 | BRL 0.0419 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.